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Abstract. The present prospective, randomized, double-blind 
study aimed to determine the impact of transversus abdominis 
plane (TAP) block on propofol and remifentanil consumption, 
when administered by closed-loop titration guided by processed 
electroencephalography, i.e., bispectral index (BIS) values. 
Following institutional review board approval, 60 patients 
were scheduled for laparoscopic colectomy under general 
anesthesia. Patients were randomly assigned to receive bilateral 
TAP block with 20 ml 0.375% ropivacaine (TAP group) or 
20 ml 0.9% saline [control (CON) group]. General anesthesia 
was maintained with propofol and remifentanil administration 
using closed-loop titration guided by BIS values. The primary 
outcome was perioperative propofol and remifentanil consump-
tion. The secondary outcomes were hypertensive or hypotensive 
events requiring treatment, recovery time in PACU and time to 
first rescue analgesia following surgery. A total of 58 patients 
participated in the present study. At similar depths of anesthesia, 
as measured by BIS during the maintenance phase (45-55), 
patients who received TAP blocks required less propofol 
(4.2±1.3 vs. 5.5±1.6 mg/kg/h; P<0.001) and remifentanil 
(0.16±0.05 vs. 0.21±0.05 µg/kg/min; P<0.001). Time to extuba-
tion was significantly shorter in the TAP group (9.8±3.2 min) 
than in the CON group (14.2±4.9 min) (P<0.05). The require-
ment to treat hemodynamic change was also significantly lower 
(P<0.05). Pain score at 2 h after surgery was also significantly 
reduced in the TAP group compared with the CON group 
(P<0.05), whereas the time to first rescue analgesia was delayed 
in patients who received TAP block (P<0.05). Postoperative 
nausea and vomiting occurred at comparable rates in each group 
(P>0.05). In conclusion, TAP block combined with general 
anesthesia reduced propofol and remifentanil consumption, 
shortened time to tracheal extubation and promoted hemody-
namic stability in laparoscopic colectomy.
Introduction
The concept of enhanced recovery after surgery (ERAS) has 
been widely accepted in clinical practice, with the benefits of 
improving outcomes and decreasing length of hospital stay (1). 
The important components of a successful anesthetic in an 
ERAS protocol are reduction of opioid use and optimized 
pain control using a multimodal approach, which includes 
neuroaxial or regional anesthesia techniques for the primary 
anesthetic (2). Transversus abdominis plane (TAP) block is 
a regional anesthesia technique that has been widely used 
in abdominal surgery (3,4). TAP block provides effective 
postoperative analgesia following abdominal surgery, and 
it can be a useful strategy to reduce perioperative opioid 
consumption, maintain intraoperative hemodynamic stability 
and promote early recovery from anesthesia (5,6). In addition, 
it is simple to perform TAP block, and there are minimal 
procedure-associated complications (7).
Although numerous studies have been performed regarding 
the impact of TAP blocks on postoperative analgesia (4-6), 
the usefulness of TAP blocks during surgery have not been 
well studied. As an important part of a multimodal analgesic 
regimen, TAP blocks can reduce intraoperative opioid 
use. Recently, closed-loop titration guided by processed 
electroencephalography, such as bispectral index (BIS), has 
become clinically applicable, and can result in improved 
anesthetic control (8). The system automates anesthetic 
administration and thus helps avoid human error (8,9). 
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This automated system may enable quantification of the 
anesthetic-sparing effect of an adjuvant, such as epidural catheter 
or TAP block for analgesia (8,9). A recent study indicated that 
thoracic epidural analgesia combined with general anesthesia 
could decrease remifentanil and propofol requirements by 
one-half and one-third when using hemodynamic criteria or 
BIS for the titration of analgesia, respectively (9).
The present study was designed to use a closed-loop 
titration system guided by BIS to quantify the effect of TAP 
blocks on the intraoperative use of propofol and remifentanil. 
The primary hypothesis was that TAP blocks may decrease 
perioperative propofol and remifentanil consumption under 
general anesthesia. Secondly, the effect of TAP blocks on 
hemodynamics, time to tracheal extubation and postoperative 
analgesia were investigated.
Materials and methods
Study protocol. This prospective, randomized, double-blind 
clinical study was approved by the local ethics committee 
clinical trials register (approval no. ChiCTR-IOR-17014
111). Following the collection of written informed consent, 
60 patients aged 18-75 years with American Society of 
Anesthesiologists physical status score II/III (3,6) scheduled 
for laparoscopic colectomy under general anesthesia were 
enrolled in the present study. Patients were recruited from 
March 1st 2017 to February 25th 2018 in Yantai Yuhuangding 
Hospital (Yantai, China).
Randomization and blinding. Patients were subjected to the 
following exclusion criteria: History of allergy to the drugs 
used in the present study, psychological disorders, infection of 
the block site, any other contraindications of TAP block, toler-
ance to opioids or use of opioids within 48 h prior to the study. 
The patients and all staff involved in patient management and 
data collection were blinded to group assignment until the end 
of the study. All TAP blocks were performed by experienced 
anesthesiologists who did not participate in data collection. 
The bilateral TAP blocks were performed under general anes-
thesia. A third anesthesiologist, who was not involved in the 
management of the patients or study, prepared the randomized 
medications. The prepared syringes contained either 20 ml 
normal saline for the CON group or 20 ml 0.375% ropivacaine 
(Qilu Pharmaceutical Co., Ltd., Jinan, China) for the TAP 
group.
Anesthesia and TAP block. The visual analogue scale (VAS) 
(0=no pain and 10=the worst possible pain) was used for 
postoperative pain assessment. On arrival at the operating 
room, patients were randomized into the control (CON) group 
(n=30) or the TAP group (n=30) using a computer-produced 
randomized list. All patients were non-invasively monitored for 
blood pressure (BP), electrocardiogram (ECG), heart rate (HR) 
and oxygen saturation (SpO2). Neuromuscular blockade was 
monitored using the CONCERT-CL neuromuscular blockade 
monitoring system provided by VERTARK Technology Co., 
Ltd. (Guangxi, China), whereas BIS was monitored using a 
BIS™ (Aspect Medical Systems, Inc., Norwood, MA, USA). 
General anesthesia was induced using 0.05 mg/kg midazolam 
(Jiangsu Nhwa Pharmaceutical Co., Ltd. Xuzhou, China), 
0.4 µg/kg sufentanil (Yichang Humanwell Pharmaceutical 
Co., Ltd., Yichang China), 1.5-2.0 mg/kg propofol (Diprivan; 
AstraZeneca, Macclesfield, UK) and 0.15 mg/kg cisatracurium 
(Jiangsu Hengrui Medicine Co., Ltd, Jiangsu, China). Following 
intubation, general anesthesia was maintained by propofol 
and remifentanil using closed-loop titration guided by BIS. 
No inhalation anesthetic was used. A previously described 
titration system and parameters of target-controlled infusion 
were used for propofol and remifentanil (Yichang Humanwell, 
Pharmaceutical Co., Ltd., Yichang, China), respectively (10-12). 
The initial target concentrations of propofol in the plasma 
(2-4 µg/ml) were selected by the anesthesiologists according 
to standard practice. The target concentration of propofol 
was automatically adjusted using the closed-loop system to 
maintain a BIS value between 45-55 during surgery. The 
target concentration of remifentanil was set at 2-8 ng/ml. The 
anesthesiologists administered the medication manually or 
switched to manual infusion during surgery if required. The 
closed-loop infusion of cisatracurium was used following 
induction guided by the reappearance of the second twitch 
during train of four stimulation. Ringer's acetate solution 
was used for volume replacement. All aspects of anesthesia 
management, except for the drug infusion, were performed by 
the anesthesiologists according to current clinical practice.
The tidal volume was set at 6-8 ml/kg and the respiratory 
rate at 12 breaths/min to maintain end-tidal CO2 tension at 
35-45 mmHg. Sufentanil was administered at 0.3 µg/kg prior 
to skin incision. TAP block was performed following induc-
tion using a similar method to that previously described (13). 
Briefly, a high-frequency linear ultrasound (US) probe 
(Venue 50; 7-12 MHz; GE Healthcare, Chicago, IL, USA) 
was placed laterally to the abdominal wall between the 
costal margin and the iliac crest on the mid axillary line. A 
satisfactory image aimed to visualize the subcutaneous fat, 
external oblique muscle, internal oblique muscle, transversus 
abdominis muscle, peritoneum and intraperitoneal cavity. The 
needle was introduced in the plane of the ultrasound probe 
directly beneath the probe and advanced until it reached 
the plane between the internal oblique and the transversus 
abdominis muscles. The correct location of the needle tip was 
confirmed by injection of 1 ml normal saline, which resulted 
in separation between the internal oblique and transversus 
abdominis muscle. Subsequently, 20 ml prepared solution was 
injected under US-directed visualization. The same steps were 
repeated on the opposite side.
Hemodynamic changes were treated according to study 
protocol. Atropine (Shandong Xinhua Pharmaceutical Co., 
Ltd., Zibo, China) was administered when HR was <45 bpm, 
esmolol (Qilu Pharmaceutical Co., Ltd.) was administered when 
HR exceeded 120 bpm, phenylephrine was administered when 
BP was <80% of the pre-induction value, and nicardipine was 
administered when systolic blood pressure exceeded 160 mmHg.
A total of 5 mg dezocine (Yangtze River Pharmaceutical 
Group, Taizhou, China) and 0.25 mg palonosetron (Qilu 
Pharmaceutical Co., Ltd.) were administered intravenously 
(IV) 30 min prior to the end of surgery. The infusion of cisa-
tracurium was stopped ~30 min prior to the end of surgery. 
Upon completion of surgery, patients were treated with 1.0 mg 
neostigmine (Shandong Xinhua Pharmaceutical Group Co., 
Ltd., Zibo, China) and 0.5 mg atropine, if necessary, to achieve 
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a T4/T1 ratio >0.9, and the propofol and remifentanil infusions 
were stopped. Patients were extubated once the extubation 
criteria were met, and time to extubation was recorded. The 
patients were transferred to the post-anesthesia care unit 
(PACU) where they received nasal O2 supplementation and 
were monitored continuously for vital signs (HR, BP, ECG and 
SpO2). Complications were recorded for 6 h postoperatively, 
including nausea, vomiting, hemodynamic instability, desatu-
ration or apnea. The VAS score at 2 h post-surgery and the 
time to the first rescue analgesic request were recorded. A total 
of 5 mg dezocine IV was administered as rescue analgesia 
when the VAS score was ≥4. A total of 4 mg ondansetron (Qilu 
Pharmaceutical Co., Ltd.) was administered IV if necessary to 
relieve nausea or vomiting.
Statistical analysis. The mean propofol dosage required for 
maintenance of anesthesia was 4.7±1.6 mg/kg/h when propofol 
and remifentanil were co-administered via closed-loop 
titration guided by BIS (14). The present study was designed to 
provide 90% power for detecting a 30% decrease in propofol 
dosage among patients receiving TAP block with a bilateral α 
risk value of 0.05. A total of 60 patients were recruited in the 
present study. All data in the present study were analyzed with 
SPSS (version 17.0; SPSS, Inc., Armonk, NY, USA). Data were 
presented as the mean ± standard deviation and count (%), as 
appropriate. Following assessment of normality, continuous 
data were compared using Student's t-test, whereas the 
Mann-Whitney test was performed to compare non-continuous 
and non-normally distributed data. χ2 or Fisher's exact tests 
were used to analyze proportions. P<0.05 was considered to 
indicate a statistically significant difference.
Results
Fig. 1 illustrates the CONSORT flow diagram of patient 
recruitment. A total of 60 patients were enrolled in the present 
trial. In the CON group, 1 patient withdrew due to surgery 
cancellation, and a further 2 patients (1 from the CON group 
and 1 from the TAP group) were excluded due to intraoperative 
blood transfusion. A total of 57 patients completed the trial (28 
in the CON group and 29 in the TAP group). Patient charac-
teristics did not differ significantly between the two groups 
(P>0.05). Demographic and surgical characteristics were 
comparable and there were no significant differences between 
the groups (Table I). The TAP block was easily localized via 
US and blocks were uneventfully performed in all patients. 
There were no complications associated with TAP block in the 
present study.
Similar depths of anesthesia (BIS number, 45-55) 
were maintained during the surgery, and the total doses 
of propofol and remifentanil used were significantly less in 
the TAP group compared with the CON group [propofol, 
4.2±1.3 vs. 5.5±1.6 mg/kg/h (P<0.001); remifentanil, 
0.16±0.05 vs. 0.21±0.05 µg/kg/min (P<0.001)]. The dose of 
cisatracurium was not significantly different between the two 
groups (P>0.05). The frequency of undesirable hemodynamic 
treatment effects (including hypotension, hypertension, brady-
cardia and tachycardia) was also significantly lower in the 
TAP group than in CON group (P<0.05; Table II).
All patients met the extubation criteria at the end of 
surgery. However, time to tracheal extubation was significantly 
shorter in the TAP group (9.8±3.2 min) than the CON group 
(14.2±4.9 min; P<0.05). VAS pain score at 2 h following 
surgery was significantly reduced in the TAP group compared 
with the CON group (P<0.05; Table II). The time to first 
rescue analgesia was significantly delayed in the TAP group 
(324±72 min) compared with the CON group (126±34 min; 
P<0.05). Postoperative nausea and vomiting occurred at 
comparable rates in each group (P>0.05).
Discussion
The results of the present study indicate that TAP blocks may 
reduce the consumption of propofol by 28% and remifentanil 
Figure 1. CONSORT flow diagram. CON, control; TAP, transversus abdominis plane.
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by 26%. Infusion with guided closed-loop titration promoted 
hemodynamic stability, shortened recovery time and improved 
postoperative analgesia.
The goal of anesthesia is to reduce acute postoperative 
pain and decrease surgical stress responses. Anesthesiologists 
serve an important role in facilitating the recovery of patients 
undergoing surgery using an ERAS protocol. Successful imple-
mentation of ERAS programs require anesthesiologists to be 
more involved in perioperative care and to be more aware of 
the impact of anesthetic techniques on surgical outcomes and 
recovery (15). Optimizing perioperative pain management while 
reducing opioid use were the major goals of the present study.
Although total intravenous anesthesia (TIVA) with propofol 
and remifentanil may be sufficient, prolonged use of TIVA 
may increase adverse effects, including delayed awakening, 
myocardial depression and hemodynamic instability (15). 
Patients undergoing abdominal surgery often suffer from 
uncontrolled postoperative pain (2,3,6). Opioids have been 
used to treat moderate to severe postoperative pain; however, 
they may cause complications such as nausea and vomiting, 
respiratory depression and circulatory depression (16,17). 
TAP block is a regional anesthetic technique that blocks 
the abdominal wall neural afferents by introducing local 
anesthetic into the fascial plane between the internal oblique 
Table II. Comparison of anesthetic procedures between the two groups during the maintenance phase.
Procedure CON group (n=28) TAP group (n=29) P-values
Propofol   
  Mean dose (mg/kg/h) 5.5±1.6 4.2±1.3 <0.001
  Mean target concentration (µg/ml)  2.7±0.7 2.1±0.5 <0.001
Remifentanil   
  Mean dose (µg/kg/min) 0.21±0.05 0.16±0.05 <0.001
  Mean target concentration (ng/ml) 6.1±1.5 4.8±1.1 <0.001
Mean dose of cisatracurium (mg/kg/h) 0.86±0.21 0.84±0.18 0.914
Undesirable hemodynamic effects   
  Hypotension requiring treatment by phenylephrine 11 (39.3) 6 (20.7) 0.021
  Hypertension requiring treatment by nicardipine  7 (25.0) 2 (7.9) 0.023
  Bradycardia requiring treatment by atropine 3 (10.7) 4 (13.7) 1.000
  Tachycardia requiring treatment by esmolol 3 (10.7) 3 (10.3) 1.000
Time to tracheal extubation (min) 14.2±4.9 9.8±3.2 0.031
Pain score at 2 h following surgery 3.4±1.6 1.8±0.6 0.014
Time to first rescue analgesia (min) 126±34 324±72 0.026
Nausea and vomiting 5 (17.8) 4 (13.8) 0.953
Continuous variables are presented as mean ± standard deviation. Categorical variables are presented as n (%). CON, control; TAP, transversus 
abdominis plane; time to tracheal extubation, time from the end of surgery to tracheal extubation.
Table I. Clinical characteristics of patients in the two groups.
Characteristic CON group (n=28) TAP group (n=29) P-value
Age (years) 58.5±11.2 59.2±10.6 0.73
Male/female 17/11 18/11 0.92
ASA grade II/III 10/18 12/17 0.66
Right/left hemicoloctomy 13/15 15/14 0.69
Weight (kg) 73.2±11.4 74.3±11.5 0.72
Height (cm) 168.2±6.1 165.9±5.8 0.15
BMI (kg/m2) 22.3±3.8 22.6±4.0 0.77
Operative time (min) 162.6±48.5 166.8±38.7 0.72
Blood loss (ml) 156±85 162±94 0.80
Infusion volume (ml) 1,864±425 1,786±501 0.53
Urine output (ml) 624±104 674±121 0.10
Categorical variables are presented as n/n. Numerical variables are presented as mean ± standard deviation. CON, control; TAP, transversus 
abdominis plane; ASA, American Society of Anesthesiologists physical status score; BMI, body mass index.
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and transversus abdominis muscles (3). Following its initial 
description in 2001 by Rafi et al (18), its use in postopera-
tive pain management has gained popularity. TAP block can 
provide effective analgesia for a variety of abdominal surgical 
procedures by decreasing somatic pain (19-21). Previously, it 
was demonstrated that TAP blocks may decrease postoperative 
pain and opioid consumption in women undergoing cesarean 
section (22). TAP block has also been demonstrated to reduce 
the use of opioids, improve pain control and expedite recovery 
in laparoscopic colorectal surgery patients (23). A previous 
meta‑analysis of the efficacy of TAP block demonstrated that it 
reduced the requirement for postoperative opioids and associ-
ated side-effects, and provided more effective pain relief (24), 
suggesting that there may be a role for TAP blocks as part 
of an effective multimodal pain regimen. Erdogan et al (5) 
demonstrated that there was significantly lower remifentanil 
consumption and anesthesia recovery time, but no signifi-
cant differences in desflurane consumption in liver transplant 
donors who received TAP block, compared with donors who 
didn't receive TAP block. Tsuchiya et al (6) reported a similar 
sparing‑effect of TAP block on sevoflurane and fentanyl use in 
abdominal surgery. In these studies, the titration of different 
anesthetics was mainly dependent on clinical hemodynamic 
criteria. However, hemodynamic changes are influenced by 
numerous variables, including preload state, pre-existing 
cardiovascular conditions, surgical blood loss and vasopressor 
usage. In the present study, anesthetic titration was performed 
with a closed loop automated system, limiting investigator 
bias. In addition, to the best of our knowledge, no previous 
studies quantified the opioid sparing effect of TAP blocks on 
propofol and remifentanil.
Anesthesiologists typically titrate anesthetics based on 
a combination of hemodynamic changes and clinical signs, 
alongside their knowledge of pharmacokinetics and pharmaco-
dynamics. The factors involved in the decision-making process 
are also subject to variations between individuals. By contrast, 
closed-loop titration used in the present study responds to 
changes in BIS values, which may result in a more objective 
mode of maintenance of anesthesia. By adding TAP blocks to 
a closed-loop protocol, distinguishing the effect of propofol 
and remifentanil on the depth of anesthesia may be possible. 
Guignard et al (25) reported in a previous controlled trial that, 
following a pain stimulus, the BIS and hemodynamics changes 
were similar. TAP blocks demonstrated a sparing effect on the 
amount of propofol and remifentanil required to maintain 
surgical anesthesia. TAP blocks also provided additional anal-
gesia by delaying the time for first rescue analgesic request, 
and VAS pain scores 2 h after surgery were lower, which is 
consistent with past meta-analysis studies (19,22,23).
Although intraoperative safety of surgical patients has 
greatly improved, cardiovascular complications still pose 
significant risks to high-risk patients with severe cardio-
vascular disease undergoing abdominal surgery (26). In the 
present study, patients who received TAP blocks exhibited less 
significant changes in hemodynamics that required treatment 
with vasopressors. These findings may be beneficial for criti-
cally ill and elderly patients who may be more vulnerable to 
changes in hemodynamics.
The time to tracheal extubation was also decreased in 
patients with TAP blocks, likely attributable to a decrease 
in total remifentanil and propofol levels. The incidence of 
postoperative nausea and vomiting was similar in both groups. 
However, the present study was not powered for this result, 
given the low incidence in patients who received total IV 
anesthesia and palonosetron prior to the end of surgery.
There are limitations of the present study. Although VAS 
scores were lower in the TAP block group, there is no objec-
tive way to evaluate the anti-nociceptive effect of TAP block. 
Secondly, only patients aged from 18-75 years were included, 
whereas elderly patients (>75 years) were not included, which 
may introduce a selection bias. A more age comprehensive 
study should be performed in the future. Finally, the impact of 
TAP blocks on the postoperative period, such as the length of 
stay in the PACU and hospital admission, were not investigated 
in the present study.
In conclusion, in laparoscopic colectomy, TAP blocks 
may reduce propofol and remifentanil consumption within 
a closed-loop anesthetic delivery system, shorten time to 
tracheal extubation and promote intraoperative hemodynamic 
stability. TAP blocks may also serve a vital role in multimodal 
analgesia for abdominal surgeries and promote enhanced 
recovery following surgery.
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